You just read:

Helsinn Announces That Pivotal Phase III Trial Data for Anamorelin in ROMANA 1 and 2 Studies in Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia will be Presented at the 38th European Society for Medical Oncology (ESMO) Congress in 2014

News provided by

Helsinn SA

25 Sep, 2014, 07:00 BST